Exhibit 99.01
CASPI SEGMENT DETAIL OF SALES REVENUE, OPERATING EARNINGS (LOSS) AND ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES
First Quarter | Second Quarter | Third Quarter | First Nine Months | |||||
| (Dollars in millions) | 2004 | 2004 | 2004 | 2004 | ||||
| Sales Revenue | ||||||||
Sales revenue - CASPI restructured, divested, and consolidated product lines(1) | $ | 174 | $ | 193 | $ | 74 | $ | 441 |
| Sales revenue - continuing product lines | 265 | 283 | 283 | 831 | ||||
| Total sales revenue | $ | 439 | $ | 476 | $ | 357 | $ | 1,272 |
| Operating Earnings (Loss) and Asset Impairments and Restructuring Charges | ||||||||
Operating loss - CASPI restructured, divested, and consolidated product lines (1) (2) | $ | (11) | $ | (72) | $ | (2) | $ | (85) |
| Operating earnings - continuing product lines | 41 | 48 | 40 | 129 | ||||
| Total Operating earnings (loss) | $ | 30 | $ | (24) | $ | 38 | $ | 44 |
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines(1) | 5 | 66 | 1 | 72 | ||||
| Asset impairments and restructuring charges - continuing product lines | 1 | 3 | 3 | 7 | ||||
| Total asset impairments and restructuring charges | $ | 6 | $ | 69 | $ | 4 | $ | 79 |
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Twelve Months | ||||||
| (Dollars in millions) | 2003 | 2003 | 2003 | 2003 | 2003 | |||||
| Sales Revenue | ||||||||||
Sales revenue - CASPI restructured, divested, and consolidated product lines(1) | $ | 174 | $ | 190 | $ | 185 | $ | 170 | $ | 719 |
| Sales revenue - continuing product lines | 237 | 251 | 236 | 240 | 964 | |||||
| Total sales revenue | $ | 411 | $ | 441 | $ | 421 | $ | 410 | $ | 1,683 |
| Operating Earnings (Loss) and Asset Impairments and Restructuring Charges | ||||||||||
Operating loss - CASPI restructured, divested, and consolidated product lines(1) (2) | $ | (31) | $ | (28) | $ | (464) | $ | (15) | $ | (538) |
| Operating earnings - continuing product lines | 28 | 47 | 29 | 32 | 136 | |||||
| Total Operating earnings (loss) | $ | (3) | $ | 19 | $ | (435) | $ | 17 | $ | (402) |
| Other Operating income | $ | -- | $ | -- | $ | -- | $ | (12) | $ | (12) |
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines (1) | 1 | 1 | 449 | 6 | 457 | |||||
| Asset impairments and restructuring charges - continuing product lines | 1 | -- | 3 | 1 | 5 | |||||
| Total asset impairments and restructuring charges | $ | 2 | $ | 1 | $ | 452 | $ | 7 | $ | 462 |
(1) These businesses and product lines include acrylate ester monomers, composites (unsaturated polyester resins), inks and graphic arts raw materials, liquid resins, powder resins and textile chemicals divested on July 31, 2004 as well as other restructuring, divestiture and consolidation activities that the Company has completed related to these businesses and product lines.
(2) Includes allocated costs consistent with the Company’s historical practices, some of which remain and were reallocated to the remainder of the segment and other segments.
81